Subcommittee on Health hearing titled "Evaluating Approaches to Diagnostic Test Regulation and the Impact of the FDA’s Proposed Rule. "Patients and providers increasingly rely on the results of diagnostics to detect, guide treatment decisions, and monitor a host of medical conditions and illnesses," said Chair Rodgers and Guthrie.